Mitsubishi Research Institute AI Stock Analysis
Want to see JP:3636 full AI Analyst Report?
Mitsubishi Research Institute (3636) AI Stock Analysis
Mitsubishi Research Institute
(TSE/TYO:3636)
The overall score of 67 reflects a company with a very strong, low-risk financial foundation and an attractive valuation, offset by weak income statement trends. The fortress balance sheet and high dividend yield are the most significant strengths, providing a margin of safety. The primary risk is the company's inability to grow revenue and the resulting pressure on profit margins and return on equity, which prevents a higher score. The stock's technical trend is supportive but not a major driver.
Mitsubishi Research Institute (3636) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 80.85B
- Dividend Yield
- 3.49%
- Average Volume (3M)
- 43.75K
- Price to Earnings (P/E)
- 12.7
- Beta (1Y)
- 0.73
- Revenue Growth
- 3.79%
- EPS Growth
- 0.50%
- Country
- Japan
- Employees
- 4,695
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Information Technology Services
Mitsubishi Research Institute Business Overview & Revenue Model
Company Description
Mitsubishi Research Institute, Inc. (MRI) is a Japanese firm that delivers a wide array of strategic advisory, information technology, and research services. It caters to a diverse client base within Japan, encompassing governmental entities, financi...
How the Company Makes Money
MRI primarily generates revenue by delivering fee-based professional services and IT solution projects. A major revenue stream comes from commissioned research and consulting engagements, where clients (including central/local government bodies and p...
Mitsubishi Research Institute Financial Statement Overview
Summary
The company's financial profile is a tale of two halves. The balance sheet is exceptional, with negligible debt and strong liquidity, earning an 85 score. Cash flow has rebounded impressively, scoring 65. However, the income statement is a drag, scoring 45 due to stalled revenue growth and margin compression. The overall financial health is solid and conservative, but top-line stagnation and declining ROE are significant concerns.
Income Statement
45NeutralBalance Sheet
85Very PositiveCash Flow
65Positive| Breakdown | TTM | Sep 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 126.06B | 126.06B | 121.46B | 115.36B | 122.13B | 116.62B |
| Gross Profit | 28.91B | 28.91B | 30.26B | 27.13B | 27.72B | 28.07B |
| EBITDA | 12.93B | 11.83B | 13.72B | 11.74B | 13.40B | 15.80B |
| Net Income | 6.42B | 6.42B | 6.39B | 5.00B | 6.29B | 7.71B |
Balance Sheet | ||||||
| Total Assets | 128.77B | 128.77B | 131.00B | 121.90B | 120.27B | 116.44B |
| Cash, Cash Equivalents and Short-Term Investments | 16.17B | 16.17B | 30.31B | 30.93B | 25.23B | 33.16B |
| Total Debt | 1.20B | 1.20B | 1.04B | 1.11B | 2.09B | 3.53B |
| Total Liabilities | 42.25B | 42.25B | 49.65B | 45.52B | 45.88B | 45.28B |
| Stockholders Equity | 77.32B | 77.32B | 71.92B | 67.63B | 65.80B | 63.05B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 5.46B | 2.81B | 12.18B | 3.09B | 7.94B |
| Operating Cash Flow | 0 | 7.81B | 6.42B | 13.54B | 5.70B | 9.26B |
| Investing Cash Flow | 0 | -2.32B | -4.00B | -2.91B | -2.41B | -6.65B |
| Financing Cash Flow | 0 | -3.43B | -3.01B | -4.94B | -6.20B | -3.85B |
Mitsubishi Research Institute Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3636, the sentiment is Positive. The current price of 5160.00 is below the 20-day moving average (MA) of 5229.25, above the 50-day MA of 5026.00, and above the 200-day MA of 4732.21, indicating a neutral trend. The MACD of 7.09 indicates Positive momentum. The RSI at 52.24 is Neutral, neither overbought nor oversold. The STOCH value of 52.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3636.
Mitsubishi Research Institute Peers Comparison
Overall Rating
JP:968286Outperform
JP:231781Outperform
JP:472579.3Outperform
JP:971571Outperform
JP:363667Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 86Outperform | JPY 178.81B | 16.19 | 19.02% | 3.11% | -0.18% | 2.75% | |
| 81Outperform | JPY 161.57B | 14.77 | ― | 3.69% | 6.46% | 8.76% | |
| 79Outperform | JPY 33.04B | 9.06 | 10.39% | 5.22% | 7.46% | 2.94% | |
| 71Outperform | JPY 130.22B | 11.53 | 9.06% | 4.03% | 5.92% | -16.28% | |
| 67Neutral | JPY 80.43B | 12.66 | ― | 3.49% | 3.79% | 0.50% | |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:3636 | Mitsubishi Research Institute | 5160.00 | 310.37 | 6.40% | |
| JP:9682 | DTS Corporation | 1188.00 | 49.71 | 4.37% | |
| JP:9715 | transcosmos | 3530.00 | -1.09 | -0.03% | |
| JP:4725 | CAC Holdings Corporation | 1917.00 | -41.72 | -2.13% | |
| JP:2317 | Systena Corporation | 461.00 | -24.11 | -4.97% |
Mitsubishi Research Institute Corporate Events
Mitsubishi Research Institute Reports Higher Fiscal 2026 Sales and Profit
Mitsubishi Research Institute provides research, consulting and information-technology services to public-sector and corporate clients in Japan, with a focus on policy, business and technology solutions. The company reported consolidated net sales of...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 05, 2026
